A detailed history of Hrt Financial LP transactions in Equillium, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 18,064 shares of EQ stock, worth $11,019. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,064
Previous 30,506 40.79%
Holding current value
$11,019
Previous $21,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.64 - $1.13 $7,962 - $14,059
-12,442 Reduced 40.79%
18,064 $14,000
Q2 2024

Aug 12, 2024

BUY
$0.66 - $2.33 $20,133 - $71,078
30,506 New
30,506 $21,000
Q1 2021

May 17, 2021

SELL
$5.03 - $10.5 $107,038 - $223,440
-21,280 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.48 - $6.58 $74,054 - $140,022
21,280 New
21,280 $113,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $21M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.